ACSL4: Biomarker, mediator and target in quadruple negative breast cancer
A new review paper titled "ACSL4: biomarker, mediator and target in quadruple negative breast cancer" has been published in Oncotarget.
Jun 14, 2023
0
16
A new review paper titled "ACSL4: biomarker, mediator and target in quadruple negative breast cancer" has been published in Oncotarget.
Jun 14, 2023
0
16
In a paper published in NAR Cancer, researchers from the Center for Childhood Cancer Research at Nationwide Children's and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of ...
Jun 14, 2023
0
3
Researchers from Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz have found a way to detect increased cancer risk associated with BRCA1 and BRCA2 mutations without genetic sequencing, ...
Jun 8, 2023
0
62
Australian cancer researchers have made an important new connection between a person's cancer risk and the functions of circular RNAs, a recently discovered family of genetic fragments present within our cells.
Jun 8, 2023
0
44
University of Virginia School of Medicine scientists have discovered a key determinant of our risk for multiple sclerosis (MS), advancing efforts to prevent and better treat the disease.
Jun 7, 2023
0
20
A new research paper titled "Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression" has been published in Oncotarget.
Jun 5, 2023
0
9
Gene alterations in biliary tract cancer offer potential targets for current or future precision therapies. This is demonstrated by a study conducted by Karl Landsteiner University of Health Sciences in collaboration with ...
May 31, 2023
0
23
New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma. Most of these genes are potential leads for the discovery of new therapies for this disease. The ...
May 29, 2023
0
94
A new method than enables researchers to dial up or tone down the amount of a certain metastatic protein inhibitor (BACH1) within a cell could provide a new path in cancer research that reassesses the effectiveness of protein ...
May 26, 2023
0
76
A new research perspective titled "HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma" has been published in Oncotarget.
May 24, 2023
0
0